ONL Therapeutics' Grant

ONL Therapeutics raised a round of funding on November 12, 2014. Investors include National Eye Institute.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly gro…

Articles about ONL Therapeutics' Grant: